(Bloomberg) -- Terry Smith slammed two of Denmark's largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they...
5 days ago

Asset manager Terry Smith, the British equivalent of US investor Warren Buffett, is frustrated with both Novo Nordisk and Coloplast.
5 days ago

Summary · Coloplast is a global leader in specialized intimate healthcare, with strong innovation, high margins, and a defensible moat in core...
1 month ago

Coloplast, a global leader in medical devices and solutions, has recently navigated a period of transition and strategic realignment as...
1 day ago

As the company is entering into a new strategy period, the Board of Directors has decided to initiate the search for a new CEO to lead Coloplast...
2 months ago

Average settlement amounts in transvaginal mesh claims in 2025 and how vaginal mesh lawsuits work after the class action lawsuit..
3 weeks ago

Coloplast A/S (($GB:0QBO)) announced an update on their ongoing clinical study. Coloplast A/S has recently completed a clinical study titled...
2 weeks ago

Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25 ... Coloplast delivered 6% organic growth in Q2, impacted by the...
2 months ago

Coloplast AS (CLPBF) reports a 6% organic growth and revises annual expectations amidst product recalls and market slowdowns.
2 months ago

The Ostomy division grew organically by 4% against expectations of 7.3%, Advanced Wound Care grew 10% against expectations of 12.4%, and...
2 months ago